Concentrix (CNXC) Financials

$24.70 +0.98 (+4.11%)

As of 11:04 AM Eastern

Annual Income Statements for Concentrix

This table shows Concentrix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	11/30/2019	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024	11/30/2025
Net Income / (Loss) Attributable to Common Shareholders	117	165	406	435	314	251	-1,279
Consolidated Net Income / (Loss)	117	165	406	436	314	251	-1,279
Net Income / (Loss) Continuing Operations	117	165	406	436	314	251	-1,279
Total Pre-Tax Income	204	268	556	605	408	299	-1,182
Total Operating Income	294	309	572	640	661	596	-918
Total Gross Profit	1,748	1,662	1,969	2,257	2,578	3,449	3,435
Total Revenue	4,708	4,720	5,587	6,324	7,115	9,619	9,826
Operating Revenue	4,708	4,720	5,587	6,324	7,115	9,619	9,826
Total Cost of Revenue	2,959	3,058	3,618	4,067	4,537	6,170	6,391
Operating Cost of Revenue	2,959	3,058	3,618	4,067	4,537	6,170	6,391
Total Operating Expenses	1,454	1,353	1,397	1,617	1,917	2,853	4,353
Selling, General & Admin Expense	1,454	1,353	1,397	1,617	1,917	2,853	2,825
Impairment Charge	-	-	-	-	0.00	0.00	1,528
Total Other Income / (Expense), net	-90	-41	-17	-35	-253	-297	-264
Interest Expense	92	48	23	70	201	322	290
Other Income / (Expense), net	2.28	7.45	6.35	35	-52	25	26
Income Tax Expense	87	103	150	169	94	48	97
Basic Earnings per Share	$2.27	$3.19	$7.78	$8.34	$5.72	$3.72	($20.36)
Weighted Average Basic Shares Outstanding	51.60M	51.60M	51.36M	51.35M	53.80M	64.98M	63.01M
Diluted Earnings per Share	$2.27	$3.19	$7.70	$8.28	$5.70	$3.71	($20.36)
Weighted Average Diluted Shares Outstanding	51.60M	51.60M	51.91M	51.74M	54.01M	65.07M	63.01M
Weighted Average Basic & Diluted Shares Outstanding	-	-	52.32M	52.07M	66.33M	64.40M	61.60M

This table shows Concentrix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024	2/28/2025	5/31/2025	8/31/2025	11/30/2025	2/28/2026
Net Income / (Loss) Attributable to Common Shareholders	78	69	52	67	17	116	70	42	88	-1,479	22
Consolidated Net Income / (Loss)	78	69	52	67	17	116	70	42	88	-1,479	22
Net Income / (Loss) Continuing Operations	78	69	52	67	17	116	70	42	88	-1,479	22
Total Pre-Tax Income	107	77	73	87	26	113	101	52	111	-1,446	29
Total Operating Income	162	180	148	150	153	145	169	148	147	-1,382	119
Total Gross Profit	594	823	857	858	864	871	856	848	855	876	850
Total Revenue	1,633	2,231	2,403	2,381	2,387	2,448	2,372	2,417	2,483	2,553	2,500
Operating Revenue	1,633	2,231	2,403	2,381	2,387	2,448	2,372	2,417	2,483	2,553	2,500
Total Cost of Revenue	1,039	1,408	1,546	1,523	1,523	1,577	1,516	1,569	1,628	1,677	1,651
Operating Cost of Revenue	1,039	1,408	1,546	1,523	1,523	1,577	1,516	1,569	1,628	1,677	1,651
Total Operating Expenses	431	642	708	707	711	726	687	700	708	2,258	731
Selling, General & Admin Expense	431	642	708	707	711	726	687	700	708	731	731
Total Other Income / (Expense), net	-55	-103	-76	-63	-127	-32	-68	-97	-36	-64	-90
Interest Expense	49	71	82	82	81	76	73	75	72	70	75
Other Income / (Expense), net	-6.17	-33	6.82	19	-46	44	4.92	-21	36	6.14	-15
Income Tax Expense	29	7.62	21	20	9.79	-2.74	31	9.63	23	33	7.14
Basic Earnings per Share	$1.50	$1.02	$0.76	$0.98	$0.25	$1.73	$1.04	$0.63	$1.34	($23.37)	$0.33
Weighted Average Basic Shares Outstanding	51.06M	53.80M	65.66M	65.27M	64.66M	64.98M	64.04M	63.36M	62.60M	63.01M	61.28M
Diluted Earnings per Share	$1.49	$1.02	$0.76	$0.98	$0.25	$1.72	$1.04	$0.63	$1.34	($23.37)	$0.33
Weighted Average Diluted Shares Outstanding	51.21M	54.01M	65.79M	65.33M	64.75M	65.07M	64.07M	63.41M	62.70M	63.01M	61.30M
Weighted Average Basic & Diluted Shares Outstanding	66.60M	66.33M	65.99M	65.33M	64.82M	64.40M	63.88M	63.03M	62.26M	61.60M	61.00M

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	11/30/2019	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024	11/30/2025
Net Change in Cash & Equivalents	138	73	27	-26	359	-87	92
Net Cash From Operating Activities	450	508	514	601	678	667	807
Net Cash From Continuing Operating Activities	448	508	514	601	678	667	807
Net Income / (Loss) Continuing Operations	117	165	406	436	314	251	-1,279
Consolidated Net Income / (Loss)	117	165	406	436	314	251	-1,279
Depreciation Expense	139	129	140	147	173	247	226
Amortization Expense	167	147	139	164	221	484	458
Non-Cash Adjustments To Reconcile Net Income	52	49	21	48	86	117	1,645
Changes in Operating Assets and Liabilities, net	-27	18	-192	-194	-117	-431	-243
Net Cash From Investing Activities	-151	-109	-79	-1,839	-2,109	-244	-250
Net Cash From Continuing Investing Activities	-121	-109	-79	-1,839	-2,109	-244	-250
Purchase of Property, Plant & Equipment	-111	-171	-149	-140	-181	-239	-234
Acquisitions	-9.43	-5.56	-3.28	-1,698	-1,914	-5.50	-16
Other Investing Activities, net	-	68	-	-	-15	0.00	0.00
Net Cash From Financing Activities	-340	-335	-402	1,238	1,803	-493	-491
Net Cash From Continuing Financing Activities	-192	-335	-402	1,238	1,803	-493	-491
Repayment of Debt	0.00	-1,485	-1,661	-2,514	-2,442	-2,407	-4,288
Repurchase of Common Equity	-	0.00	-25	-123	-64	-136	-169
Payment of Dividends	-	0.00	-13	-53	-63	-84	-90
Issuance of Debt	0.00	1,150	1,316	3,931	4,396	2,197	4,086
Other Financing Activities, net	-192	0.00	-19	-2.89	-23	-63	-32
Effect of Exchange Rate Changes	-	9.66	-7.00	-25	-12	-18	26
Cash Interest Paid	-	0.00	21	68	143	282	300
Cash Income Taxes Paid	-	77	160	144	217	298	270

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024	2/28/2025	5/31/2025	8/31/2025	11/30/2025	2/28/2026
Net Change in Cash & Equivalents	1,962	-1,608	-99	-20	44	5.42	46	60	3.35	-17	-106
Net Cash From Operating Activities	211	229	-47	238	192	284	1.41	237	225	344	-83
Net Cash From Continuing Operating Activities	211	229	-47	238	192	284	1.41	237	225	344	-83
Net Income / (Loss) Continuing Operations	78	69	52	67	17	116	70	42	88	-1,479	22
Consolidated Net Income / (Loss)	78	69	52	67	17	116	70	42	88	-1,479	22
Depreciation Expense	38	59	68	61	60	59	55	56	57	58	56
Amortization Expense	34	101	122	129	123	116	112	116	118	112	106
Non-Cash Adjustments To Reconcile Net Income	16	23	24	23	29	36	34	33	28	1,550	42
Changes in Operating Assets and Liabilities, net	46	-23	-313	-41	-36	-42	-269	-10	-66	103	-309
Net Cash From Investing Activities	-44	-1,994	-61	-60	-63	-61	-51	-56	-65	-78	-51
Net Cash From Continuing Investing Activities	-44	-1,979	-61	-60	-63	-61	-51	-56	-65	-78	-51
Purchase of Property, Plant & Equipment	-44	-65	-56	-60	-63	-60	-51	-56	-65	-63	-54
Acquisitions	-	-1,914	-4.50	-0.00	-	-1.00	-0.66	-	-	-15	0.00
Divestitures	-	-	-	-	-	-	0.00	-	-	-	3.16
Net Cash From Financing Activities	1,798	166	14	-198	-85	-224	102	-149	-165	-280	19
Net Cash From Continuing Financing Activities	1,798	180	14	-198	-85	-224	102	-149	-165	-280	19
Repayment of Debt	-664	-938	-533	-676	-582	-615	-507	-1,352	-626	-1,803	-1,702
Repurchase of Common Equity	-27	-22	-22	-41	-39	-34	-26	-45	-42	-56	-43
Payment of Dividends	-14	-21	-21	-20	-20	-23	-22	-22	-22	-23	-23
Issuance of Debt	2,502	1,166	628	555	548	466	683	1,263	533	1,608	1,803
Other Financing Activities, net	1.38	-6.14	-38	-15	8.24	-18	-24	7.28	-8.17	-6.32	-16
Effect of Exchange Rate Changes	-4.07	-9.71	-5.54	-0.43	-0.37	-	-6.58	28	8.45	-3.32	9.85

This table presents Concentrix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024	11/30/2025
Total Assets	5,178	5,046	6,670	12,492	11,991	10,761
Total Current Assets	1,423	1,543	1,754	2,859	2,842	3,085
Cash & Equivalents	153	182	145	295	241	327
Accounts Receivable	1,081	1,208	1,390	1,889	1,927	1,999
Other Current Assets	189	153	218	674	675	758
Other Current Nonoperating Assets	-	-	-	-	-	0.00
Plant, Property, & Equipment, net	452	407	404	749	715	736
Total Noncurrent Assets	3,303	3,096	4,512	8,884	8,434	6,941
Goodwill	1,836	1,814	2,904	5,079	4,987	3,672
Intangible Assets	799	656	986	2,805	2,287	1,960
Noncurrent Deferred & Refundable Income Taxes	47	48	49	72	218	317
Other Noncurrent Operating Assets	620	579	573	929	942	991
Total Liabilities & Shareholders' Equity	5,178	5,046	6,670	12,492	11,991	10,761
Total Liabilities	2,875	2,426	3,974	8,349	7,952	8,017
Total Current Liabilities	1,009	968	1,132	2,074	1,996	2,196
Short-Term Debt	34	0.00	0.00	2.31	2.52	66
Accounts Payable	141	129	161	244	210	245
Accrued Expenses	371	352	395	1,016	977	997
Current Deferred & Payable Income Tax Liabilities	21	34	69	81	100	124
Current Employee Benefit Liabilities	420	453	507	731	707	765
Other Current Nonoperating Liabilities	-	-	-	-	-	0.00
Total Noncurrent Liabilities	1,867	1,458	2,842	6,274	5,956	5,820
Long-Term Debt	1,111	802	2,224	4,940	4,733	4,573
Noncurrent Deferred & Payable Income Tax Liabilities	154	109	105	414	313	297
Other Noncurrent Operating Liabilities	602	546	512	921	910	951
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,302	2,620	2,696	4,143	4,040	2,744
Total Preferred & Common Equity	2,302	2,620	2,696	4,143	4,040	2,744
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,302	2,620	2,696	4,143	4,040	2,744
Common Stock	0.00	2,356	2,428	3,583	3,684	3,784
Retained Earnings	0.00	392	774	1,024	1,192	-177
Treasury Stock	0.00	-57	-191	-272	-421	-610
Accumulated Other Comprehensive Income / (Loss)	-3.81	-71	-316	-192	-414	-252

This table presents Concentrix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	8/31/2022	2/28/2023	5/31/2023	8/31/2023	2/29/2024	5/31/2024	8/31/2024	2/28/2025	5/31/2025	8/31/2025	2/28/2026
Total Assets	6,750	6,623	6,560	8,450	12,243	12,079	12,208	11,895	12,396	12,410	10,675
Total Current Assets	1,717	1,748	1,752	3,702	2,782	2,716	2,850	2,961	3,171	3,138	3,041
Cash & Equivalents	176	178	153	2,113	235	207	246	308	343	350	223
Accounts Receivable	1,355	1,382	1,394	1,379	1,928	1,872	1,936	2,015	2,061	2,052	2,038
Other Current Assets	186	188	205	210	619	637	668	638	766	735	573
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	208
Plant, Property, & Equipment, net	390	399	394	406	730	728	733	678	711	733	726
Total Noncurrent Assets	4,642	4,476	4,413	4,341	8,731	8,635	8,625	8,257	8,514	8,539	6,907
Goodwill	2,972	2,905	2,904	2,897	5,031	5,026	5,084	4,936	5,132	5,192	3,696
Intangible Assets	1,026	949	911	873	2,673	2,564	2,483	2,161	2,156	2,079	1,867
Noncurrent Deferred & Refundable Income Taxes	60	45	45	48	76	112	115	236	248	282	314
Other Noncurrent Operating Assets	585	577	554	523	951	933	943	924	978	986	1,030
Total Liabilities & Shareholders' Equity	6,750	6,623	6,560	8,450	12,243	12,079	12,208	11,895	12,396	12,410	10,675
Total Liabilities	4,103	3,823	3,706	5,546	8,141	7,995	8,039	7,861	8,117	8,066	7,886
Total Current Liabilities	1,028	994	1,007	1,046	1,783	1,766	1,812	1,792	1,973	2,009	2,575
Short-Term Debt	6.25	0.00	0.00	0.00	2.71	1.59	2.86	0.46	28	38	750
Accounts Payable	114	142	149	138	202	202	211	158	209	222	202
Accrued Expenses	397	393	400	398	924	936	933	920	998	970	737
Current Deferred & Payable Income Tax Liabilities	45	71	41	39	60	39	31	128	82	81	89
Current Employee Benefit Liabilities	465	389	418	470	594	589	635	585	656	699	622
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	175
Total Noncurrent Liabilities	3,075	2,829	2,698	4,500	6,358	6,229	6,227	6,069	6,144	6,057	5,311
Long-Term Debt	2,401	2,220	2,131	3,973	5,034	4,924	4,909	4,901	4,862	4,790	3,995
Noncurrent Deferred & Payable Income Tax Liabilities	159	100	77	59	386	386	378	294	311	302	301
Other Noncurrent Operating Liabilities	515	509	490	468	938	919	940	874	971	964	1,015
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,647	2,801	2,854	2,904	4,102	4,083	4,169	4,034	4,279	4,344	2,788
Total Preferred & Common Equity	2,647	2,801	2,854	2,904	4,102	4,083	4,169	4,034	4,279	4,344	2,788
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,647	2,801	2,854	2,904	4,102	4,083	4,169	4,034	4,279	4,344	2,788
Common Stock	2,416	2,447	2,459	2,472	3,606	3,628	3,654	3,712	3,738	3,766	3,814
Retained Earnings	683	848	912	976	1,056	1,102	1,099	1,240	1,260	1,326	-179
Treasury Stock	-167	-209	-214	-242	-296	-336	-376	-449	-496	-538	-656
Accumulated Other Comprehensive Income / (Loss)	-285	-286	-303	-302	-264	-310	-208	-468	-223	-209	-191

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	11/30/2019	11/30/2020	11/30/2021	11/30/2022	11/30/2023	11/30/2024	11/30/2025
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.25%	18.38%	13.20%	12.49%	35.20%	2.15%
EBITDA Growth	0.00%	-1.60%	44.67%	15.02%	1.75%	34.74%	-115.37%
EBIT Growth	0.00%	6.61%	83.03%	16.65%	-9.75%	1.95%	-243.60%
NOPAT Growth	0.00%	12.60%	119.93%	10.34%	10.29%	-1.53%	-228.39%
Net Income Growth	0.00%	40.67%	146.09%	7.41%	-27.96%	-19.95%	-609.09%
EPS Growth	0.00%	40.53%	141.38%	7.53%	-31.16%	-34.91%	-648.79%
Operating Cash Flow Growth	0.00%	12.87%	1.29%	16.83%	12.87%	-1.55%	20.90%
Free Cash Flow Firm Growth	0.00%	0.00%	115.21%	-327.42%	-226.64%	121.55%	10.67%
Invested Capital Growth	0.00%	0.00%	-1.65%	47.36%	84.09%	-2.90%	-17.33%
Revenue Q/Q Growth	0.00%	0.00%	3.06%	2.83%	9.04%	2.31%	1.08%
EBITDA Q/Q Growth	0.00%	0.00%	3.96%	4.44%	3.79%	4.35%	-115.27%
EBIT Q/Q Growth	0.00%	0.00%	6.49%	4.97%	-6.59%	7.14%	-232.44%
NOPAT Q/Q Growth	0.00%	0.00%	16.34%	-2.36%	9.06%	1.73%	-225.88%
Net Income Q/Q Growth	0.00%	0.00%	17.19%	-4.21%	-10.15%	22.51%	-504.58%
EPS Q/Q Growth	0.00%	0.00%	16.84%	-4.06%	-14.80%	23.26%	-530.44%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	13.97%	9.80%	-0.94%	9.00%	8.01%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	4.85%	-704.75%	121.13%	59.88%
Invested Capital Q/Q Growth	0.00%	0.00%	-1.13%	-2.11%	84.50%	-3.39%	-20.02%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	37.14%	35.21%	35.25%	35.69%	36.23%	35.86%	34.96%
EBITDA Margin	12.80%	12.56%	15.35%	15.60%	14.11%	14.06%	-2.12%
Operating Margin	6.25%	6.54%	10.25%	10.12%	9.30%	6.20%	-9.34%
EBIT Margin	6.30%	6.70%	10.36%	10.67%	8.56%	6.46%	-9.08%
Profit (Net Income) Margin	2.49%	3.49%	7.26%	6.89%	4.41%	2.61%	-13.02%
Tax Burden Percent	57.32%	61.52%	72.99%	72.01%	76.88%	83.94%	108.18%
Interest Burden Percent	68.92%	84.72%	96.02%	89.62%	67.01%	48.18%	132.56%
Effective Tax Rate	42.68%	38.48%	27.01%	27.99%	23.12%	16.06%	0.00%
Return on Invested Capital (ROIC)	0.00%	11.53%	12.79%	11.50%	7.50%	5.78%	-8.25%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	6.46%	11.27%	9.63%	1.71%	0.32%	-22.69%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.79%	3.69%	4.89%	1.68%	0.36%	-29.46%
Return on Equity (ROE)	0.00%	14.32%	16.48%	16.39%	9.18%	6.14%	-37.70%
Cash Return on Invested Capital (CROIC)	0.00%	-188.47%	14.45%	-26.79%	-51.70%	8.73%	10.73%
Operating Return on Assets (OROA)	0.00%	6.11%	11.32%	11.52%	6.36%	5.07%	-7.84%
Return on Assets (ROA)	0.00%	3.18%	7.93%	7.44%	3.28%	2.05%	-11.24%
Return on Common Equity (ROCE)	0.00%	14.32%	16.48%	16.39%	9.18%	6.14%	-37.70%
Return on Equity Simple (ROE_SIMPLE)	0.00%	7.16%	15.48%	16.16%	7.57%	6.22%	0.00%
Net Operating Profit after Tax (NOPAT)	169	190	418	461	508	501	-643
NOPAT Margin	3.58%	4.02%	7.48%	7.29%	7.15%	5.20%	-6.54%
Net Nonoperating Expense Percent (NNEP)	0.00%	5.07%	1.51%	1.88%	5.79%	5.46%	14.45%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	9.37%	5.60%	5.70%	-8.71%
Cost of Revenue to Revenue	62.86%	64.79%	64.75%	64.31%	63.77%	64.14%	65.04%
SG&A Expenses to Revenue	30.89%	28.66%	25.01%	25.57%	26.94%	29.66%	28.76%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.89%	28.66%	25.01%	25.57%	26.94%	29.66%	44.30%
Earnings before Interest and Taxes (EBIT)	297	316	579	675	609	621	-892
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	602	593	858	986	1,004	1,352	-208
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	3.21	2.27	1.48	0.72	0.82
Price to Tangible Book Value (P/TBV)	0.00	0.00	55.60	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	1.50	0.97	0.86	0.30	0.23
Price to Earnings (P/E)	0.00	0.00	20.73	14.07	19.54	11.60	0.00
Dividend Yield	0.00%	0.00%	0.16%	0.87%	1.22%	2.76%	3.75%
Earnings Yield	0.00%	0.00%	4.82%	7.11%	5.12%	8.62%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.79	1.72	1.23	0.87	0.93
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	1.62	1.30	1.52	0.77	0.67
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	10.53	8.31	10.74	5.48	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	15.60	12.15	17.69	11.93	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	21.61	17.79	21.20	14.80	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	17.56	13.65	15.90	11.10	8.14
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	19.12	0.00	0.00	9.80	7.85
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.00	0.50	0.31	0.83	1.19	1.17	1.69
Long-Term Debt to Equity	0.00	0.48	0.31	0.83	1.19	1.17	1.67
Financial Leverage	0.00	0.43	0.33	0.51	0.98	1.12	1.30
Leverage Ratio	0.00	2.25	2.08	2.20	2.80	2.99	3.35
Compound Leverage Factor	0.00	1.91	1.99	1.98	1.88	1.44	4.45
Debt to Total Capital	0.00%	33.22%	23.44%	45.21%	54.40%	53.96%	62.83%
Short-Term Debt to Total Capital	0.00%	0.98%	0.00%	0.00%	0.03%	0.03%	0.89%
Long-Term Debt to Total Capital	0.00%	32.24%	23.44%	45.21%	54.37%	53.94%	61.94%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	66.78%	76.56%	54.79%	45.60%	46.04%	37.17%
Debt to EBITDA	0.00	1.93	0.94	2.26	4.92	3.50	-22.31
Net Debt to EBITDA	0.00	1.67	0.72	2.11	4.63	3.32	-20.74
Long-Term Debt to EBITDA	0.00	1.87	0.94	2.26	4.92	3.50	-22.00
Debt to NOPAT	0.00	6.03	1.92	4.83	9.72	9.46	-7.22
Net Debt to NOPAT	0.00	5.22	1.48	4.51	9.14	8.98	-6.71
Long-Term Debt to NOPAT	0.00	5.85	1.92	4.83	9.72	9.45	-7.11
Altman Z-Score	0.00	0.00	3.81	2.48	1.36	1.42	0.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	0.00	1.41	1.59	1.55	1.38	1.42	1.40
Quick Ratio	0.00	1.22	1.44	1.36	1.05	1.09	1.06
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3,105	472	-1,074	-3,507	756	836
Operating Cash Flow to CapEx	404.72%	296.28%	344.90%	429.03%	375.56%	279.56%	344.13%
Free Cash Flow to Firm to Interest Expense	0.00	-64.26	20.48	-15.32	-17.45	2.35	2.88
Operating Cash Flow to Interest Expense	4.88	10.51	22.31	8.57	3.37	2.07	2.78
Operating Cash Flow Less CapEx to Interest Expense	3.67	6.96	15.84	6.57	2.48	1.33	1.97
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.00	0.91	1.09	1.08	0.74	0.79	0.86
Accounts Receivable Turnover	0.00	4.36	4.88	4.87	4.34	5.04	5.01
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	10.45	13.01	15.60	12.35	13.15	13.55
Accounts Payable Turnover	0.00	21.75	26.80	28.00	22.42	27.22	28.12
Days Sales Outstanding (DSO)	0.00	83.64	74.78	74.98	84.12	72.39	72.92
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	16.78	13.62	13.04	16.28	13.41	12.98
Cash Conversion Cycle (CCC)	0.00	66.86	61.17	61.94	67.84	58.98	59.93
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	0.00	3,295	3,240	4,775	8,790	8,535	7,056
Invested Capital Turnover	0.00	2.87	1.71	1.58	1.05	1.11	1.26
Increase / (Decrease) in Invested Capital	0.00	3,295	-54	1,535	4,015	-255	-1,479
Enterprise Value (EV)	0.00	0.00	9,028	8,200	10,779	7,409	6,566
Market Capitalization	0.00	0.00	8,408	6,121	6,132	2,914	2,254
Book Value per Share	$0.00	$44.61	$50.08	$52.18	$62.21	$62.32	$44.08
Tangible Book Value per Share	$0.00	($6.45)	$2.89	($23.11)	($56.16)	($49.90)	($46.38)
Total Capital	0.00	3,447	3,422	4,920	9,085	8,775	7,383
Total Debt	0.00	1,145	802	2,224	4,942	4,736	4,639
Total Long-Term Debt	0.00	1,111	802	2,224	4,940	4,733	4,573
Net Debt	0.00	992	620	2,079	4,647	4,495	4,311
Capital Expenditures (CapEx)	111	171	149	140	181	239	234
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	296	393	477	492	609	626
Debt-free Net Working Capital (DFNWC)	0.00	448	575	622	787	849	954
Net Working Capital (NWC)	0.00	415	575	622	785	847	888
Net Nonoperating Expense (NNE)	52	25	12	25	195	249	636
Net Nonoperating Obligations (NNO)	0.00	992	620	2,079	4,647	4,495	4,311
Total Depreciation and Amortization (D&A)	306	277	279	311	394	731	684
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	6.27%	7.03%	7.54%	6.91%	6.33%	6.38%
Debt-free Net Working Capital to Revenue	0.00%	9.50%	10.29%	9.84%	11.06%	8.83%	9.71%
Net Working Capital to Revenue	0.00%	8.79%	10.29%	9.84%	11.03%	8.80%	9.04%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$7.78	$8.34	$5.72	$3.72	($20.36)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	51.36M	51.35M	53.80M	64.98M	63.01M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$7.70	$8.28	$5.70	$3.71	($20.36)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	51.91M	51.74M	54.01M	65.07M	63.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	52.32M	52.07M	66.33M	64.40M	61.60M
Normalized Net Operating Profit after Tax (NOPAT)	169	190	418	461	508	501	427
Normalized NOPAT Margin	3.58%	4.02%	7.48%	7.29%	7.15%	5.20%	4.34%
Pre Tax Income Margin	4.34%	5.68%	9.95%	9.57%	5.74%	3.11%	-12.03%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	3.22	6.55	25.11	9.63	3.03	1.93	-3.07
NOPAT to Interest Expense	1.83	3.93	18.13	6.58	2.53	1.56	-2.21
EBIT Less CapEx to Interest Expense	2.01	3.00	18.64	7.64	2.13	1.19	-3.88
NOPAT Less CapEx to Interest Expense	0.62	0.39	11.66	4.58	1.63	0.81	-3.02
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	3.23%	12.26%	20.23%	33.36%	-7.01%
Augmented Payout Ratio	0.00%	0.00%	9.41%	40.57%	40.61%	87.54%	-20.20%

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	8/31/2023	11/30/2023	2/29/2024	5/31/2024	8/31/2024	11/30/2024	2/28/2025	5/31/2025	8/31/2025	11/30/2025	2/28/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	61,597,304.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	61,597,304.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.35
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.37%	35.96%	46.83%	47.44%	46.21%	9.74%	-1.27%	1.54%	4.01%	4.29%	5.40%
EBITDA Growth	-8.07%	13.55%	50.13%	50.79%	27.04%	18.33%	-1.29%	-15.45%	23.72%	-431.43%	-21.89%
EBIT Growth	-7.98%	-22.56%	1.92%	10.71%	-31.31%	28.05%	11.93%	-25.04%	71.09%	-828.08%	-40.13%
NOPAT Growth	4.38%	41.52%	-8.34%	-4.77%	-18.20%	-8.95%	10.84%	4.81%	20.45%	-753.61%	-24.32%
Net Income Growth	-27.53%	-33.79%	-40.71%	-15.24%	-78.58%	66.43%	34.85%	-37.02%	429.79%	-1,379.19%	-69.27%
EPS Growth	-26.96%	-49.25%	-54.76%	-35.10%	-83.22%	68.63%	36.84%	-35.71%	436.00%	-1,458.72%	-68.27%
Operating Cash Flow Growth	38.58%	-2.72%	-145.11%	78.62%	-9.36%	24.05%	103.00%	-0.76%	17.32%	21.03%	-6,010.51%
Free Cash Flow Firm Growth	115.57%	-171.37%	-1,974.06%	-2,598.57%	-1,815.36%	110.47%	109.95%	102.48%	103.24%	26.84%	265.33%
Invested Capital Growth	-2.33%	84.09%	83.87%	82.14%	85.43%	-2.90%	-3.10%	0.29%	-0.14%	-17.33%	-15.64%
Revenue Q/Q Growth	1.12%	36.62%	7.71%	-0.92%	0.28%	2.54%	-3.10%	1.90%	2.73%	2.81%	-2.06%
EBITDA Q/Q Growth	-4.30%	34.83%	12.18%	5.90%	-19.37%	25.58%	-6.41%	-12.17%	19.86%	-436.42%	122.05%
EBIT Q/Q Growth	1.90%	-5.43%	5.18%	9.22%	-36.77%	76.28%	-8.06%	-26.85%	44.31%	-850.17%	107.56%
NOPAT Q/Q Growth	-2.49%	37.86%	-34.69%	8.47%	-16.25%	53.45%	-20.49%	2.57%	-3.75%	-932.70%	109.21%
Net Income Q/Q Growth	-1.54%	-10.50%	-25.02%	28.28%	-75.12%	595.39%	-39.25%	-40.09%	109.32%	-1,779.02%	101.46%
EPS Q/Q Growth	-1.32%	-31.54%	-25.49%	28.95%	-74.49%	588.00%	-39.53%	-39.42%	112.70%	-1,844.03%	101.41%
Operating Cash Flow Q/Q Growth	58.44%	8.44%	-120.44%	608.51%	-19.60%	48.42%	-99.50%	16,699.43%	-4.96%	53.12%	-124.18%
Free Cash Flow Firm Q/Q Growth	50.18%	-1,763.12%	-2.66%	2.56%	-3.10%	110.15%	-2.38%	-75.72%	34.74%	297.19%	181.17%
Invested Capital Q/Q Growth	-1.41%	84.50%	1.29%	-1.15%	0.37%	-3.39%	1.09%	2.31%	-0.06%	-20.02%	3.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.36%	36.89%	35.65%	36.02%	36.20%	35.56%	36.08%	35.09%	34.43%	34.31%	33.98%
EBITDA Margin	13.97%	13.78%	14.36%	15.09%	12.14%	14.86%	14.35%	12.37%	14.43%	-47.24%	10.64%
Operating Margin	9.94%	8.09%	6.18%	6.31%	6.42%	5.90%	7.12%	6.14%	5.92%	-54.15%	4.74%
EBIT Margin	9.56%	6.62%	6.46%	7.12%	4.49%	7.72%	7.33%	5.26%	7.39%	-53.91%	4.16%
Profit (Net Income) Margin	4.75%	3.11%	2.17%	2.81%	0.70%	4.72%	2.96%	1.74%	3.55%	-57.95%	0.86%
Tax Burden Percent	72.69%	90.11%	71.55%	76.71%	62.96%	102.43%	69.70%	81.38%	79.06%	102.30%	75.14%
Interest Burden Percent	68.42%	52.24%	46.90%	51.38%	24.63%	59.73%	58.00%	40.68%	60.75%	105.08%	27.61%
Effective Tax Rate	27.31%	9.89%	28.45%	23.29%	37.04%	-2.43%	30.30%	18.62%	20.94%	0.00%	24.86%
Return on Invested Capital (ROIC)	9.78%	7.65%	5.07%	6.14%	5.59%	6.72%	5.43%	5.45%	5.15%	-47.78%	4.46%
ROIC Less NNEP Spread (ROIC-NNEP)	7.81%	4.88%	3.49%	4.69%	3.14%	6.01%	4.42%	3.76%	4.54%	-59.40%	2.97%
Return on Net Nonoperating Assets (RNNOA)	5.75%	4.80%	3.46%	4.53%	2.90%	6.71%	5.10%	4.16%	4.87%	-77.11%	3.96%
Return on Equity (ROE)	15.53%	12.44%	8.53%	10.67%	8.49%	13.43%	10.53%	9.62%	10.03%	-124.88%	8.42%
Cash Return on Invested Capital (CROIC)	12.03%	-51.70%	-51.80%	-50.95%	-52.62%	8.73%	8.94%	5.56%	5.93%	10.73%	8.44%
Operating Return on Assets (OROA)	8.21%	4.91%	5.40%	6.61%	4.09%	6.07%	5.82%	4.14%	5.83%	-46.56%	3.67%
Return on Assets (ROA)	4.08%	2.31%	1.81%	2.60%	0.63%	3.71%	2.35%	1.37%	2.80%	-50.05%	0.76%
Return on Common Equity (ROCE)	15.53%	12.44%	8.53%	10.67%	8.49%	13.43%	10.53%	9.62%	10.03%	-124.88%	8.42%
Return on Equity Simple (ROE_SIMPLE)	12.03%	0.00%	6.78%	6.52%	4.92%	0.00%	6.68%	5.72%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	118	163	106	115	96	148	118	121	116	-968	89
NOPAT Margin	7.22%	7.29%	4.42%	4.84%	4.04%	6.05%	4.96%	4.99%	4.68%	-37.90%	3.56%
Net Nonoperating Expense Percent (NNEP)	1.97%	2.77%	1.58%	1.44%	2.45%	0.71%	1.01%	1.70%	0.61%	11.62%	1.49%
Return On Investment Capital (ROIC_SIMPLE)	-	1.79%	1.16%	-	-	1.69%	1.32%	1.32%	1.27%	-13.11%	1.18%
Cost of Revenue to Revenue	63.64%	63.11%	64.35%	63.98%	63.80%	64.44%	63.92%	64.91%	65.57%	65.69%	66.02%
SG&A Expenses to Revenue	26.42%	28.80%	29.47%	29.71%	29.78%	29.66%	28.96%	28.95%	28.51%	28.62%	29.24%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.42%	28.80%	29.47%	29.71%	29.78%	29.66%	28.96%	28.95%	28.51%	88.46%	29.24%
Earnings before Interest and Taxes (EBIT)	156	148	155	170	107	189	174	127	183	-1,376	104
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	228	307	345	359	290	364	341	299	358	-1,206	266
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.41	1.48	1.15	0.99	1.18	0.72	0.72	0.84	0.77	0.82	0.72
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.63	0.86	0.60	0.47	0.52	0.30	0.30	0.37	0.34	0.23	0.20
Price to Earnings (P/E)	11.69	19.54	16.95	15.14	23.97	11.60	10.80	14.61	10.52	0.00	0.00
Dividend Yield	1.40%	1.22%	1.63%	1.94%	1.61%	2.76%	2.81%	2.32%	2.52%	3.75%	4.22%
Earnings Yield	8.55%	5.12%	5.90%	6.60%	4.17%	8.62%	9.26%	6.84%	9.51%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.25	1.23	1.07	0.99	1.08	0.87	0.87	0.92	0.88	0.93	0.90
Enterprise Value to Revenue (EV/Rev)	0.91	1.52	1.21	1.01	1.02	0.77	0.78	0.84	0.80	0.67	0.66
Enterprise Value to EBITDA (EV/EBITDA)	6.15	10.74	8.51	7.09	7.39	5.48	5.57	6.28	5.73	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	9.11	17.69	15.54	13.92	16.53	11.93	11.73	13.60	11.59	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	12.75	21.20	18.99	17.63	19.47	14.80	14.78	15.76	15.28	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.69	15.90	18.05	13.84	15.64	11.10	10.48	11.38	10.44	8.14	9.06
Enterprise Value to Free Cash Flow (EV/FCFF)	10.25	0.00	0.00	0.00	0.00	9.80	9.57	16.57	14.91	7.85	9.75
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.37	1.19	1.23	1.21	1.18	1.17	1.22	1.14	1.11	1.69	1.70
Long-Term Debt to Equity	1.37	1.19	1.23	1.21	1.18	1.17	1.22	1.14	1.10	1.67	1.43
Financial Leverage	0.74	0.98	0.99	0.97	0.92	1.12	1.15	1.11	1.07	1.30	1.33
Leverage Ratio	2.74	2.80	2.73	2.69	2.92	2.99	2.97	2.93	2.89	3.35	3.31
Compound Leverage Factor	1.87	1.46	1.28	1.38	0.72	1.79	1.72	1.19	1.76	3.52	0.91
Debt to Total Capital	57.78%	54.40%	55.12%	54.67%	54.09%	53.96%	54.86%	53.34%	52.64%	62.83%	62.99%
Short-Term Debt to Total Capital	0.00%	0.03%	0.03%	0.02%	0.03%	0.03%	0.01%	0.31%	0.41%	0.89%	9.96%
Long-Term Debt to Total Capital	57.78%	54.37%	55.09%	54.66%	54.06%	53.94%	54.85%	53.03%	52.23%	61.94%	53.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	42.22%	45.60%	44.88%	45.33%	45.91%	46.04%	45.14%	46.66%	47.36%	37.17%	37.01%
Debt to EBITDA	4.11	4.92	4.50	3.99	3.79	3.50	3.64	3.78	3.55	-22.31	-16.80
Net Debt to EBITDA	1.92	4.63	4.29	3.82	3.60	3.32	3.41	3.52	3.29	-20.74	-16.01
Long-Term Debt to EBITDA	4.11	4.92	4.50	3.99	3.79	3.50	3.64	3.76	3.52	-22.00	-14.15
Debt to NOPAT	8.52	9.72	10.05	9.93	9.98	9.46	9.65	9.49	9.46	-7.22	-7.00
Net Debt to NOPAT	3.99	9.14	9.58	9.51	9.48	8.98	9.05	8.82	8.77	-6.71	-6.67
Long-Term Debt to NOPAT	8.52	9.72	10.04	9.92	9.98	9.45	9.65	9.43	9.38	-7.11	-5.89
Altman Z-Score	1.81	1.24	1.25	1.29	1.39	1.30	1.34	1.33	1.34	0.74	1.15
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.54	1.38	1.56	1.54	1.57	1.42	1.65	1.61	1.56	1.40	1.18
Quick Ratio	3.34	1.05	1.21	1.18	1.20	1.09	1.30	1.22	1.20	1.06	0.88
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	232	-3,853	-3,955	-3,854	-3,974	403	394	96	129	512	1,438
Operating Cash Flow to CapEx	481.19%	353.72%	-83.61%	396.66%	305.39%	475.02%	2.78%	423.96%	345.56%	546.10%	-154.39%
Free Cash Flow to Firm to Interest Expense	4.70	-54.64	-47.98	-46.74	-49.17	5.30	5.39	1.27	1.79	7.31	19.10
Operating Cash Flow to Interest Expense	4.29	3.25	-0.57	2.89	2.37	3.74	0.02	3.14	3.12	4.92	-1.10
Operating Cash Flow Less CapEx to Interest Expense	3.40	2.33	-1.25	2.16	1.59	2.95	-0.67	2.40	2.22	4.02	-1.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.86	0.74	0.84	0.93	0.91	0.79	0.79	0.79	0.79	0.86	0.88
Accounts Receivable Turnover	4.77	4.34	4.76	5.30	5.67	5.04	4.86	4.89	4.88	5.01	4.91
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	16.38	12.35	13.96	15.41	16.51	13.15	13.62	13.38	13.26	13.55	14.18
Accounts Payable Turnover	33.19	22.42	29.23	31.50	34.40	27.22	34.07	30.10	29.06	28.12	36.20
Days Sales Outstanding (DSO)	76.49	84.12	76.63	68.92	64.35	72.39	75.04	74.57	74.86	72.92	74.31
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.00	16.28	12.49	11.59	10.61	13.41	10.71	12.12	12.56	12.98	10.08
Cash Conversion Cycle (CCC)	65.49	67.84	64.14	57.34	53.74	58.98	64.33	62.45	62.30	59.93	64.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,764	8,790	8,904	8,802	8,834	8,535	8,628	8,827	8,822	7,056	7,278
Invested Capital Turnover	1.35	1.05	1.15	1.27	1.38	1.11	1.09	1.09	1.10	1.26	1.25
Increase / (Decrease) in Invested Capital	-114	4,015	4,061	3,969	4,070	-255	-276	25	-13	-1,479	-1,349
Enterprise Value (EV)	5,945	10,779	9,516	8,747	9,580	7,409	7,502	8,123	7,803	6,566	6,543
Market Capitalization	4,084	6,132	4,714	4,029	4,915	2,914	2,908	3,575	3,325	2,254	2,020
Book Value per Share	$55.78	$62.21	$62.46	$61.88	$63.81	$62.32	$62.64	$66.98	$68.93	$44.08	$45.27
Tangible Book Value per Share	($16.65)	($56.16)	($54.85)	($53.14)	($52.02)	($49.90)	($47.56)	($47.11)	($46.44)	($46.38)	($45.05)
Total Capital	6,877	9,085	9,138	9,009	9,080	8,775	8,936	9,169	9,172	7,383	7,534
Total Debt	3,973	4,942	5,037	4,925	4,912	4,736	4,902	4,891	4,828	4,639	4,745
Total Long-Term Debt	3,973	4,940	5,034	4,924	4,909	4,733	4,901	4,862	4,790	4,573	3,995
Net Debt	1,861	4,647	4,802	4,718	4,665	4,495	4,594	4,548	4,478	4,311	4,523
Capital Expenditures (CapEx)	44	65	56	60	63	60	51	56	65	63	54
Debt-free, Cash-free Net Working Capital (DFCFNWC)	544	492	767	744	795	609	861	883	816	626	993
Debt-free Net Working Capital (DFNWC)	2,656	787	1,002	951	1,041	849	1,169	1,226	1,166	954	1,216
Net Working Capital (NWC)	2,656	785	999	950	1,038	847	1,168	1,197	1,128	888	466
Net Nonoperating Expense (NNE)	40	93	54	48	80	32	47	79	28	512	67
Net Nonoperating Obligations (NNO)	1,861	4,647	4,802	4,718	4,665	4,495	4,594	4,548	4,478	4,311	4,490
Total Depreciation and Amortization (D&A)	72	160	190	190	183	175	167	172	175	170	162
Debt-free, Cash-free Net Working Capital to Revenue	8.33%	6.91%	9.73%	8.61%	8.45%	6.33%	8.98%	9.17%	8.39%	6.38%	9.98%
Debt-free Net Working Capital to Revenue	40.71%	11.06%	12.71%	11.00%	11.07%	8.83%	12.19%	12.73%	11.99%	9.71%	12.22%
Net Working Capital to Revenue	40.71%	11.03%	12.68%	10.98%	11.04%	8.80%	12.19%	12.44%	11.61%	9.04%	4.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.50	$1.02	$0.76	$0.98	$0.25	$1.73	$1.04	$0.63	$1.34	($23.37)	$0.33
Adjusted Weighted Average Basic Shares Outstanding	51.06M	53.80M	65.66M	65.27M	64.66M	64.98M	64.04M	63.36M	62.60M	63.01M	61.28M
Adjusted Diluted Earnings per Share	$1.49	$1.02	$0.76	$0.98	$0.25	$1.72	$1.04	$0.63	$1.34	($23.37)	$0.33
Adjusted Weighted Average Diluted Shares Outstanding	51.21M	54.01M	65.79M	65.33M	64.75M	65.07M	64.07M	63.41M	62.70M	63.01M	61.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.60M	66.33M	65.99M	65.33M	64.82M	64.40M	63.88M	63.03M	62.26M	61.60M	61.00M
Normalized Net Operating Profit after Tax (NOPAT)	118	163	106	115	96	101	118	121	116	-968	89
Normalized NOPAT Margin	7.22%	7.29%	4.42%	4.84%	4.04%	4.13%	4.96%	4.99%	4.68%	-37.90%	3.56%
Pre Tax Income Margin	6.54%	3.46%	3.03%	3.66%	1.11%	4.61%	4.25%	2.14%	4.49%	-56.65%	1.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.17	2.09	1.88	2.06	1.33	2.48	2.38	1.69	2.55	-19.68	1.38
NOPAT to Interest Expense	2.39	2.31	1.29	1.40	1.19	1.95	1.61	1.60	1.61	-13.84	1.18
EBIT Less CapEx to Interest Expense	2.28	1.17	1.20	1.33	0.55	1.70	1.69	0.95	1.64	-20.58	0.67
NOPAT Less CapEx to Interest Expense	1.50	1.39	0.61	0.67	0.42	1.16	0.92	0.86	0.71	-14.74	0.47
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	16.37%	20.23%	25.10%	28.50%	39.89%	33.36%	31.77%	35.72%	28.16%	-7.01%	-6.81%
Augmented Payout Ratio	32.38%	40.61%	52.30%	70.34%	100.18%	87.54%	83.84%	94.97%	74.75%	-20.20%	-20.82%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, bottom-line view of Concentrix (CNXC) using the quarterly statements from the last four years. The company shows some positive operating trends in 2023–2025, but faces a notable earnings setback in Q4 2025 alongside sizable financing and investing activity.

Revenue growth in late 2025: Q4 2025 operating revenue of $2.552B versus Q4 2024’s $2.448B (about +4.3%).
Operating cash flow remains positive across recent periods, with Q4 2025 net cash from continuing operating activities at about $344.2M, and prior quarters also showing positive cash flow from operations.
Debt financing activity provides liquidity in Q4 2025: issuance of debt around $1.61B, complemented by sizable debt repayments in the quarter, indicating active balance-sheet management.
Asset base trend supports liquidity: total assets rose from about $11.9B in 2024 to roughly $12.41B in 2025.
Earnings per share were positive in several quarters (for example, Q3 2025 EPS $1.34; Q1 2025 EPS $1.04; Q2 2025 EPS $0.63), signaling periods of improving profitability.
Positive financing activity in early 2025: net cash from continuing financing activities in Q1 2025 was around $179.7M, indicating liquidity support from financing sources during that period.
Profitability margins are steady but modest: 2025 gross margins have generally been in the low-to-mid 30s percentage range (Q4 2025 gross margin around 34%; Q4 2024 around 35.6%).
Leverage levels are elevated but stable: long-term debt roughly $4.8–$5.0B and total liabilities around $8.0–$8.3B across 2023–2025, implying ongoing debt load to fund operations and growth.
Q4 2025 net income collapses: consolidated net income to common shareholders falls to about -$1.48B, with basic EPS of -$23.37, marking a material quarterly earnings setback.
Cash flow pressure in the quarter due to investing/financing outflows: net change in cash and equivalents for Q4 2025 is a negative $17.36M, driven by large investing and financing outlays despite positive operating cash flow.

05/07/26 08:42 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Concentrix's Financials

When does Concentrix's fiscal year end?

According to the most recent income statement we have on file, Concentrix's financial year ends in November. Their financial year 2025 ended on November 30, 2025.

How has Concentrix's net income changed over the last 6 years?

Concentrix's net income appears to be on a downward trend, with a most recent value of -$1.28 billion in 2025, falling from $117.16 million in 2019. The previous period was $251.22 million in 2024. View Concentrix's forecast to see where analysts expect Concentrix to go next.

What is Concentrix's operating income?

Concentrix's total operating income in 2025 was -$918.18 million, based on the following breakdown:

Total Gross Profit: $3.44 billion
Total Operating Expenses: $4.35 billion

How has Concentrix's revenue changed over the last 6 years?

Over the last 6 years, Concentrix's total revenue changed from $4.71 billion in 2019 to $9.83 billion in 2025, a change of 108.7%.

How much debt does Concentrix have?

Concentrix's total liabilities were at $8.02 billion at the end of 2025, a 0.8% increase from 2024, and a 178.8% increase since 2020.

How much cash does Concentrix have?

In the past 5 years, Concentrix's cash and equivalents has ranged from $145.38 million in 2022 to $327.35 million in 2025, and is currently $327.35 million as of their latest financial filing in 2025.

How has Concentrix's book value per share changed over the last 6 years?

Over the last 6 years, Concentrix's book value per share changed from 0.00 in 2019 to 44.08 in 2025, a change of 4,408.1%.

Related Companies

Financial statements for NASDAQ:CNXC last updated on 4/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concentrix (CNXC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Concentrix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concentrix (CNXC) Financials

Annual Income Statements for Concentrix

Quarterly Income Statements for Concentrix

Annual Cash Flow Statements for Concentrix

Quarterly Cash Flow Statements for Concentrix

Annual Balance Sheets for Concentrix

Quarterly Balance Sheets for Concentrix

Annual Metrics And Ratios for Concentrix

Quarterly Metrics And Ratios for Concentrix

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Concentrix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools